MD1977F2 - Method of prognosticating the cardiac insufficiency syndrome course - Google Patents
Method of prognosticating the cardiac insufficiency syndrome course Download PDFInfo
- Publication number
- MD1977F2 MD1977F2 MD20000092A MD20000092A MD1977F2 MD 1977 F2 MD1977 F2 MD 1977F2 MD 20000092 A MD20000092 A MD 20000092A MD 20000092 A MD20000092 A MD 20000092A MD 1977 F2 MD1977 F2 MD 1977F2
- Authority
- MD
- Moldova
- Prior art keywords
- effort
- course
- athenolol
- values
- arterial pressure
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000004873 systolic arterial blood pressure Effects 0.000 abstract 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 abstract 1
- 208000000059 Dyspnea Diseases 0.000 abstract 1
- 206010013975 Dyspnoeas Diseases 0.000 abstract 1
- 230000001919 adrenal effect Effects 0.000 abstract 1
- 229940097217 cardiac glycoside Drugs 0.000 abstract 1
- 239000002368 cardiac glycoside Substances 0.000 abstract 1
- 229960005156 digoxin Drugs 0.000 abstract 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 abstract 1
- 229960003401 ramipril Drugs 0.000 abstract 1
- 229930002534 steroid glycoside Natural products 0.000 abstract 1
- 150000008143 steroidal glycosides Chemical class 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to medicine, in particular to cardiology. Summary of the invention consists in that it is carried out the clinical, paraclinical examination, within which it is carried out the cycloergometry, according to which it is determined the effort stopping criterion, the applied treatment, besides the adrenal blockers, additionally includes administration of peripheral vasodilating preparations and of cardiac glycosides, and the discriminant function (F) is calculated according to the formula:F=2,241-1,145ATA-10,937AICT+0,040ATAS-0,002ADP+0,005ATASM+0,695ACIE,whereinTA - the index characterizing the applied treatment and, depending on the used preparations, receives the values: 1 (Athenolol), 2 (Athenolol+Ramipril), 3 (Isorbinitrate+Digoxin)ICT - cardiothoracal indexTAS - systolic arterial pressure (without effort)DP - double product (units)TASM - systolic arterial pressure with maximum effortCIE - effort stopping criterion, which takes the values: 1 for dyspnea, 2 for submaximum CCF, on the basis of which there are determined the variants of the cardiac insufficiency syndrome course. When F>0 it is prognosticated an effect of improvement, and when F<0 - an effect of aggravation.Claims: 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000092A MD1977G2 (en) | 2000-05-26 | 2000-05-26 | Method of prognosticating the cardiac insufficiency syndrome course |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000092A MD1977G2 (en) | 2000-05-26 | 2000-05-26 | Method of prognosticating the cardiac insufficiency syndrome course |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MD20000092A MD20000092A (en) | 2001-12-31 |
| MD1977F2 true MD1977F2 (en) | 2002-08-31 |
| MD1977G2 MD1977G2 (en) | 2003-02-28 |
Family
ID=19739600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20000092A MD1977G2 (en) | 2000-05-26 | 2000-05-26 | Method of prognosticating the cardiac insufficiency syndrome course |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1977G2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3181G2 (en) * | 2005-10-24 | 2007-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of prognosticating the risk of development of nosocomial septico-purulent infections |
| MD301Z (en) * | 2010-06-02 | 2011-07-31 | Николай АРМЕНЧА | Method for estimating the functional state of the human cardiovascular system |
-
2000
- 2000-05-26 MD MDA20000092A patent/MD1977G2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MD20000092A (en) | 2001-12-31 |
| MD1977G2 (en) | 2003-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5966898A (en) | Detecting atherosclerosis in humans | |
| ATE405277T1 (en) | SUBSTITUTION INFUSION FLUID AND CITRATE ANTICOAGULATION | |
| MD306C2 (en) | Remedy for prophylactic of vascular diseases dependent on glycoproteinfixed peroxides action | |
| TW221445B (en) | ||
| MXPA02004598A (en) | Novel compounds to treat diabetes and associated conditions. | |
| MD1977G2 (en) | Method of prognosticating the cardiac insufficiency syndrome course | |
| Auer et al. | Headache as a manifestation of fatal myocardial infarction | |
| AU2002249692A1 (en) | Method for reducing cellular damage resulting from hypoxia/ischaemia-related inflammation | |
| CA2456507A1 (en) | Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander | |
| Gorback et al. | The accuracy of rapid oscillometric blood pressure determination | |
| DE69913716T2 (en) | INHIBITION OF SICKENING OF ERYTHROCYTES BY N-L-ALPHA-ASPARTYL-L-PHENYL ALANINE 1-METHYL ESTER | |
| IT1229271B (en) | MEDICINAL PREPARATION OF AN EXTRACT OF THE NETTLE ROOTS, URTICA KIOVENSIS (ROGOWICZ), ITS USE FOR CANCER TREATMENT AND PREPARATION PROCESS. | |
| RU2007119C1 (en) | Method for taking donors' blood | |
| McGovern Jr et al. | Hemodynamics of an anastomotic arteriovenous fistula | |
| RU93000004A (en) | SUBSTANCE FOR TREATMENT OF SUBCUTANEOUS FIBRASARCOMA AND METHOD FOR ITS OBTAINING | |
| Cohn et al. | Pulmonary embolectomy during pregnancy | |
| Zanetti et al. | Long-term follow-up of blood pressure after extracorporeal shock wave lithotripsy | |
| JPS55143912A (en) | Useful preparation comprising bencyclane fumarate | |
| 王宝泉 et al. | CLINICAL AND EXPERIMENTAL STUDIES ON “SHENGJI (TISSUE-GROWING)” OINTMENT IN INFECTED OPEN FRACTURES | |
| RU2258513C2 (en) | Method for protecting cerebrum and cervico-suprathoracic department of spinal cord against ischemia at reconstructive operations upon thoracic aorta | |
| GR3006147T3 (en) | ||
| RU2003278C1 (en) | Method of determining arterial pressure | |
| Joo et al. | Prophylactic milrinone may decrease the incidence of myocardial ischemia during opcab surgery | |
| Parshina | THz therapy and smoking: facts and hypotheses | |
| EP0739633A3 (en) | Use of antithrombin III to increase placental blood flow |